The Psychedelics and Health Research Initiative at UC San Diego has received a $1.3 million grant from the Steven and Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.
COVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside, weigh…
The latest edition of the UC Davis Children’s Hospital Annual Report is now available. The publication covers2019-2020, an historic year that included the coronavirus and the separation of craniopagus twins.
Surgical resident Jennifer Geiger has received a $30,000 research grant to devise a new curriculum that teaches residents how to better communicate with patients facing end-of-life decisions.
The American Association of Critical-Care Nurses (AACCN) recently conferred a gold-level Beacon Award of Excellence on the neonatal intensive care unit (NICU) at UCLA Santa Monica Medical Center.
UC Davis Comprehensive Cancer Center Director Primo “Lucky” Lara, Jr. helped author a clinical trial testing the best treatment for metastatic papillary kidney cancer. The promising results are published in The Lancet.
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
UC San Diego clinical trial suggests ivabradine may be effective in treating postural orthostatic tachycardia syndrome, a potential COVID-19 long-hauler symptom.
Health Media Contacts
Find the best contact for health-related media inquiries.
